Role of Genetic Variations in Determining Treatment Outcome in Head and Neck Cancer
Worldwide, head and neck squamous cell carcinoma (HNSCC) is responsible for >550,000 diagnoses and 380,000 deaths annually. It originates in the upper aerodigestive tract and has a multifactorial origin involving both genetic and lifestyle risk factors. The clinical management of HNSCC involves s...
Main Author: | Munindra Ruwali |
---|---|
Format: | Article |
Language: | English |
Published: |
European Medical Journal
2017-11-01
|
Series: | European Medical Journal |
Subjects: | |
Online Access: | https://www.emjreviews.com/oncology/article/role-of-genetic-variations-in-determining-treatment-outcome-in-head-and-neck-cancer/ |
Similar Items
-
Brain-Derived Neurotropic Factor, Vascular Endothelial Growth Factor and Matrix Metalloproteinases as Markers of Metabolic Status in Non-Growth Hormone-Treated Girls With Turner Syndrome
by: Ewa Błaszczyk, et al.
Published: (2021-08-01) -
The role of MMP-2 and MMP-9 in the metastasis and development of hypopharyngeal carcinoma
by: Zhe Song, et al.
Published: (2021-09-01) -
The role of matrix metalloproteinases in development of psoriasis and associated comorbidity
by: Khotko A.A.
Published: (2013-09-01) -
Glomerular expression of matrix metalloproteinases in systemic lupus erythematosus in association with activity index and renal function
by: Konstantinos N. Adamidis, et al.
Published: (2019-01-01) -
Matrix metalloproteinase 3 polymorphisms as a potential marker of enhanced susceptibility to lung cancer in chronic obstructive pulmonary disease subjects
by: Kamil Brzóska, et al.
Published: (2014-09-01)